Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Trauma (Emergency, Injury, Surgery) | Family Medicine

Heart Attack (Myocardial Infarction) Clinical Trials

A listing of Heart Attack (Myocardial Infarction) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

Research Site
Alexander City Alabama

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Pfizer Investigational Site
Athens Alabama 35611
Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Athens Alabama 35611
Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Research Site
Athens Alabama

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Novartis Investigative Site
Birmingham Alabama 35235-3424

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

View More »

Novartis Investigative Site
Birmingham Alabama 35209

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Birmingham Alabama 35294-2041

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Research Site
Birmingham Alabama
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Cardiology, P.C.
Birmingham Alabama 35211
Updated

Patients are needed to participate in a clinical research study evaluating Sodium Alginate and Calcium Gluconate and Saline Solution for the treatment of Acute Myocardial Infarction, Congestive Heart Failure or ST-Elevation Myocardial Infarction

Research Site
Birmingham Alabama

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Research Site
Hunstville Alabama
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Research Site
Huntsville Alabama

A clinical research study for the treatment of Stable Coronary Artery Disease (CAD), Myocardial Infarction

Novartis Investigative Site
Huntsville Alabama 35801

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Pfizer Investigational Site
Huntsville Alabama 35801
Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Research Site
Huntsville Alabama
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Research Site
Millbrook Alabama

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Novartis Investigative Site
Mobile Alabama 36617-2293

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Mobile Alabama 36604

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Mobile Alabama 36608

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Mobile Alabama

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Research Site
Mobile Alabama

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Research Site
Montgomery Alabama
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Research Site
Muscle Shoals Alabama
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Research Site
Ozark Alabama

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Alaska

Novartis Investigative Site
Anchorage Alaska 99508

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Arizona

Research Site
Cottonwood Arizona
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Mercy Gilbert and Chandler Medical Center
Gilbert Arizona 85224

A clinical research study of ALLOGENEIC MESENCHYMAL BONE MARROW CELLS for the treatment of ST Segment Elevation Myocardial Infarction (STEMI) or Allogeneic Mesenchymal Bone Marrow Cells

Novartis Investigative Site
Glendale Arizona 85302

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Pfizer Investigational Site
Glendale Arizona 85308
Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Research Site
Glendale Arizona
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

View More »

Research Site
Mesa Arizona

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Novartis Investigative Site
Phoenix Arizona 85032

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Phoenix Arizona 85018

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Research Site
Phoenix Arizona

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Pfizer Investigational Site
Tempe Arizona 85282
Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Tempe Arizona 85282
Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Pfizer Investigational Site
Tucson Arizona 85710
Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Research Site
Tucson Arizona
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Pfizer Investigational Site
Tucson Arizona 85710
Updated

A Phase 3 clinical study for patients with Cardiovascular Disease

Arkansas

Novartis Investigative Site
Hot Springs Arkansas 71913

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Jonesboro Arkansas 72401

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Jonesboro Arkansas

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Novartis Investigative Site
Little Rock Arkansas 72204

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Research Site
Little Rock Arkansas
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

California

Research Site
Alhambra California

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Research Site
Anaheim California
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Research Site
Bakersfield California
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

Research Site
Bakersfield California

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Novartis Investigative Site
Beverly Hills California 90211

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

View More »

Research Site
Beverly Hills California
Updated

A clinical trial to evaluate treatments using Ticagrelor 90 mg and Ticagrelor placebo for patients with Diabetes Mellitus, Type 2

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last